A TNF‐p100 pathway subverts noncanonical NF‐κB signaling in inflamed secondary lymphoid organs
暂无分享,去创建一个
Anna George | Meenakshi Chawla | Soumen Basak | S. Rath | A. George | S. Basak | Vineeta Bal | V. Bal | Satyajit Rath | Tapas Mukherjee | Budhaditya Chatterjee | Atika Dhar | Sachendra S Bais | Payel Roy | Meenakshi Chawla | P. Roy | Tapas Mukherjee | Sachendra S. Bais | B. Chatterjee | Atika Dhar
[1] C. Leonardi,et al. A transient benign lymph node-based proliferation of T-cells simulating non-Hodgkin lymphoma in a patient with psoriasis treated with tumor necrosis factor alpha and CD11a antagonists , 2008, Diagnostic pathology.
[2] C. Benedict,et al. Specific Remodeling of Splenic Architecture by Cytomegalovirus , 2006, PLoS pathogens.
[3] C. Ware,et al. p100/IκBδ sequesters and inhibits NF-κB through kappaBsome formation , 2014, Proceedings of the National Academy of Sciences.
[4] J. Caamaño,et al. A Stroma-Derived Defect in NF-κB2−/− Mice Causes Impaired Lymph Node Development and Lymphocyte Recruitment1 , 2004, The Journal of Immunology.
[5] Robert P. Jenkins,et al. Dendritic Cells Control Fibroblastic Reticular Network Tension and Lymph Node Expansion , 2014, Nature.
[6] J. Kapp,et al. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses , 1995, European journal of immunology.
[7] Alexander Hoffmann,et al. Generation and Activation of Multiple Dimeric Transcription Factors within the NF-κB Signaling System , 2008, Molecular and Cellular Biology.
[8] M. Dorf,et al. PKC phosphorylation of TRAF2 mediates IKKalpha/beta recruitment and K63-linked polyubiquitination. , 2009, Molecular cell.
[9] T. Mak,et al. Activation of noncanonical NF-κB requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, TRAF3 and the kinase NIK , 2008, Nature Immunology.
[10] P. Roy,et al. Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway , 2016, Oncogene.
[11] J. Gommerman,et al. Lymphotoxin-sensitive microenvironments in homeostasis and inflammation , 2012, Front. Immun..
[12] S. Perrin,et al. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. , 2005, Immunity.
[13] Z. Ronai,et al. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF‐κB , 2004, The EMBO journal.
[14] T. Hara,et al. Lymph Node Fibroblastic Reticular Cells Construct the Stromal Reticulum via Contact with Lymphocytes , 2004, The Journal of experimental medicine.
[15] S. Perrin,et al. Lymphotoxin-β Receptor Signaling Is Required for the Homeostatic Control of HEV Differentiation and Function , 2005 .
[16] F. Weih,et al. RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF , 2003, The EMBO journal.
[17] V. Dixit,et al. Signaling to NF-kappaB: regulation by ubiquitination. , 2010, Cold Spring Harbor perspectives in biology.
[18] S. Turley,et al. Stromal infrastructure of the lymph node and coordination of immunity. , 2015, Trends in immunology.
[19] T. Junt,et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue–inducer cells with stroma of the T cell zone , 2008, Nature Immunology.
[20] S. Abraham,et al. Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines , 2009, Nature Medicine.
[21] Scott N. Mueller,et al. Regulation of Homeostatic Chemokine Expression and Cell Trafficking During Immune Responses , 2007, Science.
[22] B. Aronow,et al. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers , 2004 .
[23] Y. Piao,et al. Cellular source and molecular form of TNF specify its distinct functions in organization of secondary lymphoid organs. , 2010, Blood.
[24] C. Snapper,et al. Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses , 1998, The Journal of experimental medicine.
[25] S. Choudhary,et al. Inducible Tumor Necrosis Factor (TNF) Receptor-associated Factor-1 Expression Couples the Canonical to the Non-canonical NF-κB Pathway in TNF Stimulation* , 2013, The Journal of Biological Chemistry.
[26] D. Green,et al. RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. , 2003, The Journal of biological chemistry.
[27] J. Keats,et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling , 2008, Nature Immunology.
[28] F. Weih,et al. Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines1 , 2001, The Journal of Immunology.
[29] D. Green,et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. , 2002, Immunity.
[30] Simon Mitchell,et al. Signaling via the NFκB system , 2016, Wiley interdisciplinary reviews. Systems biology and medicine.
[31] Shao-Cong Sun. The noncanonical NF‐κB pathway , 2012, Immunological reviews.
[32] A. Hoffmann,et al. Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues. , 2006, Blood.
[33] S. Pizzo,et al. Mast cell–derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection , 2003, Nature Immunology.
[34] A. Hoffmann,et al. Control of RelB during dendritic cell activation integrates canonical and non-canonical NF-κB pathways , 2012, Nature Immunology.
[35] E. Schwarz,et al. TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood , 2008, Arthritis research & therapy.
[36] D. Green,et al. RelB/p50 dimers are differentially regulated by TNF-α and lymphotoxin-β receptor activation: critical roles for p100 , 2003 .
[37] G. Cheng,et al. Rescue of TRAF3-null mice by p100 NF-κB deficiency , 2006, The Journal of experimental medicine.
[38] 原渕 保明,et al. 扁桃組織における lymphotoxin beta receptor の発現 , 2007 .
[39] C. Ware,et al. Allosteric Regulation of the Ubiquitin:NIK and Ubiquitin:TRAF3 E3 Ligases by the Lymphotoxin-β Receptor* , 2010, The Journal of Biological Chemistry.
[40] Alexander Hoffmann,et al. Lessons from mathematically modeling the NF‐κB pathway , 2012, Immunological reviews.
[41] B. Aronow,et al. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. , 2004, The EMBO journal.
[42] J. Cyster,et al. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. , 2005, Annual review of immunology.
[43] U. Klein,et al. Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development , 2016, Proceedings of the National Academy of Sciences.
[44] Alexander Hoffmann,et al. Kinetic control of negative feedback regulators of NF-κB/RelA determines their pathogen- and cytokine-receptor signaling specificity , 2009, Proceedings of the National Academy of Sciences.
[45] J. Cyster,et al. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen , 2022 .
[46] D. Green,et al. The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .